fda compounding semaglutide warning november 2025 The Risks of Compounded Products Compounded "semaglutide" is not FDA-approved

These compounds have not been evaluated by regulatory health authorities

Semaglutide and tirzepatide have been under shortage pressure since 2023 as demand for the branded formulations (Ozempic, Wegovy, Mounjaro, Zepbound) outpaced manufacturing capacity

Tissue Barriers 12:2292461

Try relaxing activities, including taking a bath, reading fiction, poetry, or scripture, crossword puzzles, journaling, coloring, drawing, puzzles, and meditation

Few real-world studies yet show how GLP-1s affect hospitalizations, employee productivity, or healthcare utilization at scale

Nika Steward has lost 104 pounds and no longer obsesses over food